JAMI LYNN DODSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CORPUS CHRISTI, TX NPI 1942559331

General Payments — all program years on this page

$5,763.74

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 344
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $434.99 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $434.9921

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $1,687.71108
2022 $2,895.39172
2023 $745.6543
2024 $434.9921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086938269 Novartis Pharmaceuticals Corporation $27.10 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086938273 Novartis Pharmaceuticals Corporation $12.75 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086938277 Novartis Pharmaceuticals Corporation $79.03 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086938279 Novartis Pharmaceuticals Corporation $21.01 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100380847 Novo Nordisk Inc $21.51 10/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100391436 Novo Nordisk Inc $23.30 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104624594 AstraZeneca Pharmaceuticals LP $15.54 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105340026 AstraZeneca Pharmaceuticals LP $18.13 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105778642 AstraZeneca Pharmaceuticals LP $14.28 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107031069 ABBVIE INC. $15.73 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107031071 ABBVIE INC. $18.52 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107031073 ABBVIE INC. $16.08 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117542954 Amgen Inc. $17.79 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125350842 Abbott Laboratories $19.64 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135672772 Lilly USA, LLC $16.34 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135707146 Lilly USA, LLC $16.33 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141742819 Merck Sharp & Dohme LLC $19.04 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146763470 IDORSIA PHARMACEUTICALS US INC $16.86 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150121171 SHIELD THERAPEUTICS INC $15.39 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150141566 SHIELD THERAPEUTICS INC $16.29 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150151836 SHIELD THERAPEUTICS INC $14.33 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.